EUVIMEDEUVIMED entdecken
Crossref

Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma

Xulei Wang, Wenshi Tian, Yihan Zhao, Yihui He, Zhengyang Zhang, Xiaobo Shao, Yunchao Wang, Jianning Wang iD

Journal of Biophotonics · 2026

DOI: 10.1002/jbio.202500546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biophotonics, 2026. Verfasst von Xulei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institu…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Deep Learning, Kidney Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Taishan Scholars Program of Shandong Province, Natural Science Foundation of Shandong Province Youth Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma (ccRCC), the most common aggressive renal cancer subtype, shows marked heterogeneity that hinders recurrence prediction.

Objective

To evaluate hyperspectral pathology imaging (HSI) with deep learning for individualized recurrence risk prediction in ccRCC.

Methods

Slides from 48 patients with ccRCC were imaged using a 400–1000 nm hyperspectral microscope. Spectral data were preprocessed, and a dual‐branch network (HSI‐FusionNet) extracted spatial and spectral features via 2D and 1D convolution, followed by gated fusion and multiple instance learning (MIL) for patient‐level prediction.

Results

HSI‐FusionNet achieved strong test performance (area under the receiver operating characteristic curve [AUC] = 0.912; sensitivity = 0.881; specificity = 0.846), outperforming ResNet‐50, 1D‐Convolutional Neural Network (CNN), and a 1D‐Transformer. Recurrence‐related spectral bands (530–580 and 830–900 nm) reflected hemoglobin and lipid–collagen differences.

Conclusion

HSI with deep learning accurately identifies recurrent ccRCC and reveals molecular–metabolic signatures, supporting precision postoperative risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellDeep LearningKidney NeoplasmsNeoplasm Recurrence, LocalHyperspectral ImagingHumansMiddle AgedMaleFemale

Stichwörter der Autor:innen

clear cell renal cell carcinomadeep learninghyperspectral imagingrecurrence predictionspectral‐spatial fusion

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Nephrology, Jinan, China.
  • Department of Urology, Shandong Provincial Qianfoshan Hospital, Shandong University Cheeloo College of Medicine, Jinan, China.
  • Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Urology, Zibo Zhoucun People's Hospital, Zibo, China.

ORCID-Profile: Jianning Wang

Förderung

  • Taishan Scholars Program of Shandong Province
  • Natural Science Foundation of Shandong Province Youth Project
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Tian, W., Zhao, Y., He, Y., Zhang, Z., Shao, X., Wang, Y., & Wang, J. (2026). Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma. Journal of Biophotonics. https://doi.org/10.1002/jbio.202500546

Vancouver

Wang X, Tian W, Zhao Y, He Y, Zhang Z, Shao X, et al. Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma. Journal of Biophotonics. 2026. doi:10.1002/jbio.202500546

BibTeX
@article{Wang2026,
  author = {Wang, Xulei and Tian, Wenshi and Zhao, Yihan and He, Yihui and Zhang, Zhengyang and Shao, Xiaobo and Wang, Yunchao and Wang, Jianning},
  title = {Deep Learning on Hyperspectral Pathology for Recurrence Prediction in Clear Cell Renal Cell Carcinoma},
  journal = {Journal of Biophotonics},
  year = {2026},
  doi = {10.1002/jbio.202500546}
}
Kostenlos starten →